Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Alpine Immune Sciences Inc.

Alpine Immune Sciences Announces Participation in September Investor Conferences
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN EVO
Alpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directors
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
Alpine Immune Sciences Announces Update on ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and Other Autoimmune and Inflammatory Diseases, at EULAR 2022
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
AACR 2022: Davoceticept (ALPN-202) Monotherapy Reduces Tumors, Supports Multiple Expansion Cohorts
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
Alpine Immune Sciences Announces Company Presentation and Update on AACR Investor Event
From Alpine Immune Sciences Inc.
Via Business Wire
Tickers ALPN
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.